Literature DB >> 26401039

Vpr Enhances Tumor Necrosis Factor Production by HIV-1-Infected T Cells.

Ferdinand Roesch1, Léa Richard1, Réjane Rua1, Françoise Porrot2, Nicoletta Casartelli2, Olivier Schwartz3.   

Abstract

UNLABELLED: The HIV-1 accessory protein Vpr displays different activities potentially impacting viral replication, including the arrest of the cell cycle in the G2 phase and the stimulation of apoptosis and DNA damage response pathways. Vpr also modulates cytokine production by infected cells, but this property remains partly characterized. Here, we investigated the effect of Vpr on the production of the proinflammatory cytokine tumor necrosis factor (TNF). We report that Vpr significantly increases TNF secretion by infected lymphocytes. De novo production of Vpr is required for this effect. Vpr mutants known to be defective for G2 cell cycle arrest induce lower levels of TNF secretion, suggesting a link between these two functions. Silencing experiments and the use of chemical inhibitors further implicated the cellular proteins DDB1 and TAK1 in this activity of Vpr. TNF secreted by HIV-1-infected cells triggers NF-κB activity in bystander cells and allows viral reactivation in a model of latently infected cells. Thus, the stimulation of the proinflammatory pathway by Vpr may impact HIV-1 replication in vivo. IMPORTANCE: The role of the HIV-1 accessory protein Vpr remains only partially characterized. This protein is important for viral pathogenesis in infected individuals but is dispensable for viral replication in most cell culture systems. Some of the functions described for Vpr remain controversial. In particular, it remains unclear whether Vpr promotes or instead prevents proinflammatory and antiviral immune responses. In this report, we show that Vpr promotes the release of TNF, a proinflammatory cytokine associated with rapid disease progression. Using Vpr mutants or inhibiting selected cellular genes, we show that the cellular proteins DDB1 and TAK1 are involved in the release of TNF by HIV-infected cells. This report provides novel insights into how Vpr manipulates TNF production and helps clarify the role of Vpr in innate immune responses and inflammation.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26401039      PMCID: PMC4645299          DOI: 10.1128/JVI.02098-15

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  114 in total

Review 1.  Dynamic roles for NF-κB in HTLV-I and HIV-1 retroviral pathogenesis.

Authors:  Jonathan K Chan; Warner C Greene
Journal:  Immunol Rev       Date:  2012-03       Impact factor: 12.988

2.  Viral protein R of human immunodeficiency virus types 1 and 2 is dispensable for replication and cytopathogenicity in lymphoid cells.

Authors:  D Dedera; W Hu; N Vander Heyden; L Ratner
Journal:  J Virol       Date:  1989-07       Impact factor: 5.103

3.  Exogenous HIV-1 Vpr disrupts IFN-alpha response by plasmacytoid dendritic cells (pDCs) and subsequent pDC/NK interplay.

Authors:  Henoch Sangjoon Hong; Nupur Bhatnagar; Matthias Ballmaier; Ulrich Schubert; Peter Henklein; Thorsten Volgmann; Hans Heiken; Reinhold E Schmidt; Dirk Meyer-Olson
Journal:  Immunol Lett       Date:  2009-06-25       Impact factor: 3.685

4.  Tumor necrosis factor stimulates transcription of HIV-1 in human T lymphocytes, independently and synergistically with mitogens.

Authors:  N Israël; U Hazan; J Alcami; A Munier; F Arenzana-Seisdedos; F Bachelerie; A Israël; J L Virelizier
Journal:  J Immunol       Date:  1989-12-15       Impact factor: 5.422

5.  Activation of transcription factors NF-kappaB and NF-IL-6 by human immunodeficiency virus type 1 protein R (Vpr) induces interleukin-8 expression.

Authors:  P Roux; C Alfieri; M Hrimech; E A Cohen; J E Tanner
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

6.  HIV-1 Vpr suppresses immune activation and apoptosis through regulation of nuclear factor kappa B.

Authors:  V Ayyavoo; A Mahboubi; S Mahalingam; R Ramalingam; S Kudchodkar; W V Williams; D R Green; D B Weiner
Journal:  Nat Med       Date:  1997-10       Impact factor: 53.440

Review 7.  Cytokine production and dysregulation in HIV pathogenesis: lessons for development of therapeutics and vaccines.

Authors:  Morgan A Reuter; Carolina Pombo; Michael R Betts
Journal:  Cytokine Growth Factor Rev       Date:  2012-06-27       Impact factor: 7.638

8.  Interactions between human immunodeficiency virus (HIV)-1 Vpr expression and innate immunity influence neurovirulence.

Authors:  Hong Na; Shaona Acharjee; Gareth Jones; Pornpun Vivithanaporn; Farshid Noorbakhsh; Nicola McFarlane; Ferdinand Maingat; Klaus Ballanyi; Carlos A Pardo; Eric A Cohen; Christopher Power
Journal:  Retrovirology       Date:  2011-06-06       Impact factor: 4.602

9.  Exposed hydrophobic residues in human immunodeficiency virus type 1 Vpr helix-1 are important for cell cycle arrest and cell death.

Authors:  R Anthony Barnitz; Benjamin Chaigne-Delalande; Diane L Bolton; Michael J Lenardo
Journal:  PLoS One       Date:  2011-09-16       Impact factor: 3.240

10.  HIV-1 Vpr-mediated G2 arrest involves the DDB1-CUL4AVPRBP E3 ubiquitin ligase.

Authors:  Jean-Philippe Belzile; Ghislaine Duisit; Nicole Rougeau; Johanne Mercier; Andrés Finzi; Eric A Cohen
Journal:  PLoS Pathog       Date:  2007-07       Impact factor: 6.823

View more
  10 in total

1.  Virion-Associated Vpr Alleviates a Postintegration Block to HIV-1 Infection of Dendritic Cells.

Authors:  Caitlin M Miller; Hisashi Akiyama; Luis M Agosto; Ann Emery; Chelsea R Ettinger; Ronald I Swanstrom; Andrew J Henderson; Suryaram Gummuluru
Journal:  J Virol       Date:  2017-06-09       Impact factor: 5.103

2.  HIV-1 Vpr degrades the HLTF DNA translocase in T cells and macrophages.

Authors:  Hichem Lahouassa; Marie-Lise Blondot; Lise Chauveau; Ghina Chougui; Marina Morel; Marjorie Leduc; François Guillonneau; Bertha Cecilia Ramirez; Olivier Schwartz; Florence Margottin-Goguet
Journal:  Proc Natl Acad Sci U S A       Date:  2016-04-25       Impact factor: 11.205

Review 3.  Mechanisms of Human Immunodeficiency Virus-Associated Lymphocyte Regulated Cell Death.

Authors:  Ana C Paim; Andrew D Badley; Nathan W Cummins
Journal:  AIDS Res Hum Retroviruses       Date:  2019-12-10       Impact factor: 2.205

Review 4.  The HIV-1 Vpr Protein: A Multifaceted Target for Therapeutic Intervention.

Authors:  María Eugenia González
Journal:  Int J Mol Sci       Date:  2017-01-10       Impact factor: 5.923

Review 5.  Targeting TNF and TNF Receptor Pathway in HIV-1 Infection: from Immune Activation to Viral Reservoirs.

Authors:  Sébastien Pasquereau; Amit Kumar; Georges Herbein
Journal:  Viruses       Date:  2017-03-30       Impact factor: 5.048

6.  TASOR epigenetic repressor cooperates with a CNOT1 RNA degradation pathway to repress HIV.

Authors:  Sophie Lanciano; Pauline Larrous; Benjamin Martin; Roy Matkovic; Marina Morel; Fabienne Bejjani; Virginie Vauthier; Maike M K Hansen; Stéphane Emiliani; Gael Cristofari; Sarah Gallois-Montbrun; Florence Margottin-Goguet
Journal:  Nat Commun       Date:  2022-01-10       Impact factor: 14.919

7.  Virion encapsidated HIV-1 Vpr induces NFAT to prime non-activated T cells for productive infection.

Authors:  Kristin Höhne; Ramona Businger; Anouk van Nuffel; Sebastian Bolduan; Herwig Koppensteiner; Ann Baeyens; Jolien Vermeire; Eva Malatinkova; Bruno Verhasselt; Michael Schindler
Journal:  Open Biol       Date:  2016-07       Impact factor: 6.411

8.  Primate lentiviruses use at least three alternative strategies to suppress NF-κB-mediated immune activation.

Authors:  Dominik Hotter; Teresa Krabbe; Elisabeth Reith; Ali Gawanbacht; Nadia Rahm; Ahidjo Ayouba; Benoît Van Driessche; Carine Van Lint; Martine Peeters; Frank Kirchhoff; Daniel Sauter
Journal:  PLoS Pathog       Date:  2017-08-31       Impact factor: 6.823

9.  Distinct MCM10 Proteasomal Degradation Profiles by Primate Lentiviruses Vpr Proteins.

Authors:  Hao Chang; Lowela Siarot; Ryosuke Matsuura; Chieh-Wen Lo; Hirotaka Sato; Hiroyuki Otsuki; Yoko Aida
Journal:  Viruses       Date:  2020-01-15       Impact factor: 5.048

10.  HIV Vpr Modulates the Host DNA Damage Response at Two Independent Steps to Damage DNA and Repress Double-Strand DNA Break Repair.

Authors:  Donna Li; Andrew Lopez; Carina Sandoval; Randilea Nichols Doyle; Oliver I Fregoso
Journal:  mBio       Date:  2020-08-04       Impact factor: 7.867

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.